"82491-025-10" National Drug Code (NDC)

NDC Code	82491-025-10
Package Description	1 VIAL, GLASS in 1 CARTON (82491-025-10) / 1 INJECTION in 1 VIAL, GLASS
Product NDC	82491-025
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Lytenava
Non-Proprietary Name	Bevacizumab-vikg
Dosage Form	INJECTION
Usage	INTRAVITREAL
Start Marketing Date	20260716
Marketing Category Name	BLA
Application Number	BLA761320
Manufacturer	Outlook Therapeutics, Inc.
Substance Name	BEVACIZUMAB
Strength	1.25
Strength Unit	mg/1
Pharmacy Classes	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]